Editorial

• Volume 3 Number 2 – December 2010

Special reports

• US Department of Health and Human Services Guidelines for the use of antiretroviral agents in HIV-1-positive adults and adolescents publish a special section on HIV and IDUs

Conference reports

• European Association of the Study of the Liver Monothematic Conference on Hepatitis D

• Needs of neglected disease going unmet: a conference overview

• XVIII International AIDS Conference: 18–23 July 2010, Vienna

• Navigating the IAS Vienna conference online

• The Lancet series: Global HIV epidemic among people who use drugs

• HTLV-II molecular epidemiology from HIV-1-positive Spanish injecting drug users

• Injecting drug use and ART: monitoring survival on treatment

• Dopaminergic signaling: a common neuropathogenic mechanism in the etiology of opiate addiction and neuro-AIDS

• Characteristics of peripheral blood mononuclear cells of injecting drug users

• High frequency of methicillin-resistant staphylococci detection at post-injecting pyo-inflammatory complications in HIV-infected injecting drug users

• Poorer antiretroviral therapy outcomes in HIV-positive injecting drug users in Vietnam

• Crystal methamphetamine injection predicts slower HIV RNA suppression among injection drug users

• Methadone based integrated care for IDUs in Dnipropetrovsk region of Ukraine

• Risk factors for depression among intravenous drug users (IDUs) receiving antiretroviral (ARV) treatment in Jakarta and Bali, Indonesia

• Effective strategy to scale-up HIV services among injecting drug users (IDUs) in prisons in Bulgaria

• Predictors of weight gain in a cohort of HIV-positive injection drug users (IDUs) initiating antiretroviral (ARV) therapy in Hanoi, Vietnam

• Clinical and laboratory predictors of FIB-4 elevations in HCV moinofected and HCV/HIV co-infected patients

• Cortisol response to stress in HIV-positive IDUs is related to depression

• The impact of injection drug use cessation and antiretroviral therapy on smoking cessation among HIV-infected injection drug users in Baltimore, MD 1988-2008

Drug interactions

• Pharmacokinetic interactions between buprenorphine/naloxone and once daily lopinavir/ritonavir

Activist opinion

• Worsening access to treatment for IDUs in the Russian Federation linked to the interruptions in ARV supply

Other news

• Reference Group to the UN on HIV and Injecting Drug Use releases Consensus Statement of recommendations for global action

• The International HIV/AIDS Alliance issues a good practice guide on harm reduction

• Hepatitis E vaccine candidate completely blocked disease

• A new report “Sinning and sinned against: the stigmatisation of problem drug users” by the UK Drug Policy Commission

On the web

• Web resources

• Future meetings: conference listing

PDFs

• Volume 3 Number 2 December 2010